Skip to main content
. 2023 Sep 29;12(19):2384. doi: 10.3390/cells12192384

Table 1.

Details of selected ZOL-1 responder and non-responder human-derived glioblastoma tumor cell lines.

Glioblastoma (GS) Sample ID * Responder/Non-Responder New/Recurrent Ethnicity Sex (M/F) Age EGFR CNV PTEN CNV PTEN MUT
GS054 Non-Responder Recurrent White F 59 Shallow Deletion G44D
GS122 ** Non-Responder Recurrent White M 40 Amplified Shallow Deletion
GS147 *** Non-Responder Recurrent White M 59 Amplified Shallow Deletion
GS154 Non-Responder Recurrent Latino M 51 Copy Number Gain
GS194 + Non-Responder Recurrent White M 52 Amplified Shallow Deletion
GS023 Responder New Mexican F 47 X342_splice
GS025 Responder Recurrent White F 39 Amplified
GS118 + Responder Recurrent White M 74 Shallow Deletion
GS152 & Responder New Black M 61 Shallow Deletion N292Kfs*6
GS130 $ Responder Recurrent White F 61 Shallow Deletion X70_splice

* All cases diagnosed were glioblastoma, IDH-wildtype; ** GS122 had detected EGFR vIII expression; *** GS147 had a PIK3CA mutation (E39K); + GS194 (A289V) and GS118 (R108K) had EGFR mutations; & GS152 tumor line was xenografted into mice to establish the GBX1152 tumor line; $ GS130 tumor line was xenografted into mice to establish the XDS4130 tumor line.